tiprankstipranks
Marvel Biosciences Corp (TSE:MRVL)
:MRVL
Canadian Market
MRVL
Marvel Biosciences Corp
RESEARCH TOOLSreports
Want to see TSE:MRVL full AI Analyst Report?

Marvel Biosciences Corp (MRVL) Stock News & Sentiment

43 Followers
Marvel Biosciences Advances MB-204 With High-Bioavailability Pediatric Liquid Formulations
Premium
Company Announcements
Marvel Biosciences Advances MB-204 With High-Bioavailability Pediatric Liquid Formulations
19d ago
Marvel Biosciences Advances Pediatric MB-204 Formulations for Neurodevelopmental Disorders
Premium
Company Announcements
Marvel Biosciences Advances Pediatric MB-204 Formulations for Neurodevelopmental Disorders
19d ago
Marvel Biosciences Lowers Conversion Price on Proposed Debenture Financing
Premium
Company Announcements
Marvel Biosciences Lowers Conversion Price on Proposed Debenture Financing
22d ago
Marvel Biosciences to Raise Up to $500,000 via Convertible Debenture Offering
Premium
Company Announcements
Marvel Biosciences to Raise Up to $500,000 via Convertible Debenture Offering
27d ago
Marvel Biosciences Wins Non-Dilutive Backing for MB-204 Phase I Trial
Premium
Company Announcements
Marvel Biosciences Wins Non-Dilutive Backing for MB-204 Phase I Trial
28d ago
Marvel Biosciences Wins Alberta Funding to Advance MB-204 Into Phase I Trials
Premium
Company Announcements
Marvel Biosciences Wins Alberta Funding to Advance MB-204 Into Phase I Trials
1M ago
Marvel Biosciences Taps Novotech to Run Phase I Trial of Lead Neurodrug MB-204
Premium
Company Announcements
Marvel Biosciences Taps Novotech to Run Phase I Trial of Lead Neurodrug MB-204
1M ago
More TSE:MRVL News >

MRVL News on the Web

Marvel Biosciences Advances MB-204 With High-Bioavailability Pediatric Liquid Formulations
TipRanks News
Bullish
Marvel Biosciences Advances Pediatric MB-204 Formulations for Neurodevelopmental Disorders
TipRanks News
Neutral
Marvel Biosciences Lowers Conversion Price on Proposed Debenture Financing
TipRanks News
Neutral
Marvel Biosciences to Raise Up to $500,000 via Convertible Debenture Offering
TipRanks News
Neutral
Marvel Biosciences Wins Non-Dilutive Backing for MB-204 Phase I Trial
TipRanks News
Neutral
Marvel Biosciences Wins Alberta Funding to Advance MB-204 Into Phase I Trials
TipRanks News
Neutral
Marvel Biosciences Taps Novotech to Run Phase I Trial of Lead Neurodrug MB-204
TipRanks News
Neutral
Marvel Biosciences Wins Key U.S. Patent for Lead Neurology Drug MB-204
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
TSE:MRVL
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:MRVL’s Media Buzz Sentiment?
2 articles about TSE:MRVL were published this week. In an average week, 1.75 articles are published.
    What is TSE:MRVL’s weekly average amount of articles?
    In an average week, 1.75 articles about TSE:MRVL are published.
      What is TSE:MRVL’s News Sentiment?
      Currently, no data Available
      General Stocks that are Trending in the News
      JANJanus Living, Inc. Class A
      GMTLGuardian Metal Resources PLC Sponsored ADR
      0IIHKering SA
      OMGOmai Gold Mines
      Showing the stocks with the most bullish news sentiment over the past week